Evidence map›Paper›PMID 40160597›Full record

ArticleReviews in cardiovascular medicine2025

The Path for Men from Young Adulthood Results of Cognitive Tests to Subclinical Atherosclerosis at Age 60: The Mediating Role of Socioeconomic Status, Lifestyle and Cardiovascular Disease Risk Factors-Results from a VIPVIZA Study.

Margareta Norberg, Per Liv, Ulf Näslund, Per Wester, Elin M Andersson, Steven Nordin

Registry-linked trialAbstract read
In one paragraph

Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01849575 (Direct VIsualiZAtion of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention. A Population Based Pragmatic Randomised Controlled Trial Within Västerbotten Intervention Programme), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01849575 naactive not recruitingnot on this map

Direct VIsualiZAtion of Asymptomatic Atherosclerotic Disease for Optimum Cardiovascular Prevention. A Population Based Pragmatic Randomised Controlled Trial Within Västerbotten Intervention Programme (VIP) and Ordinary Care.

TypeinterventionalSponsorUmeå UniversityRan2013 to 2027Enrolled3,532ConditionsCardiovascular DiseasesArmsIntervention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Margareta NorbergDepartment of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0003-2475-7131
Per LivDepartment of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0002-5494-8134
Ulf NäslundDepartment of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0003-4100-8298
Per WesterDepartment of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0003-0394-5096
Elin M AnderssonDepartment of Psychology, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0002-9847-4196
Steven NordinDepartment of Psychology, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0003-1699-1681

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The role of cognitive abilities in the development of arteriosclerotic disease is still not fully understood. The purpose of the present study was to evaluate the mediating role of lifestyle, socioeconomic status (SES) and conventional cardiovascular disease (CVD) risk factors in the association between cognitive ability at age 19 and subclinical atherosclerosis at age 60 years. Methods: An observational study design was employed. Data on the results from cognitive tests of conscripts tested at age 19 were collected for 1009 men. At the age of 60, they were included in the trial VIsualiZation of asymptomatic Atherosclerotic disease for optimum cardiovascular prevention, which was conducted as part of the Västerbotten Intervention Program (VIPVIZA). VIPVIZA is a randomised controlled trial, aimed at primary prevention of CVD in Västerbotten County, Sweden. Prior to any intervention, they underwent carotid ultrasonography and CVD risk factor assessment. Lifestyle habits and marital status were self-reported, and education and urban or rural residency were registered. Crude associations between cognitive ability at age 19 and the risk of CVD, assessed with the European Systematic Coronary Risk Evaluation 2 (SCORE2), as well as subclinical atherosclerosis, as demonstrated by the presence of carotid plaques (no plaque, plaque unilateral, or plaque bilateral), were evaluated. A path-analytic model tested mediating factors from cognitive ability in young adulthood to subclinical atherosclerosis at age 60. Results: Results from cognitive tests at age 19 were in separate unadjusted analyses inversely and linearly associated with SCORE2 and with subclinical atherosclerosis. The association with carotid plaque at age 60 was mainly indirect and mediated by adult SES, which in turn had its main effect through adherence to healthy lifestyle habits via CVD risk of carotid plaques. Conclusions: Cognitive ability at age 19 is a factor that is upstream of adult SES and our study indicates that cognitive ability at a young age has long-term consequences via SES and lifestyle habits for CVD risk and atherosclerosis. Clinical Trial Registration: NCT01849575, https://clinicaltrials.gov/study/NCT01849575?term=NCT01849575&rank=1.

Indexed as

atherosclerosiscardiovascular riskcognitive abilitylifestylesocioeconomic status

Identifiers

PMID40160597
PMCPMC11951286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.